Phase II study evaluating lapatinib in combination withnab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
Denise A. Yardley, Lowell Hart, Linda Bosserman, Mansoor N. Salleh, David M. Waterhouse, Maura K. Hagan, Paul Richards, Michelle L. DeSilvio, Janine M. Mahoney, Yasir NagarwalaVolume:
137
Langue:
english
DOI:
10.1007/s10549-012-2341-9
Date:
January, 2013
Fichier:
PDF, 202 KB
english, 2013